|
1
|
Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.
|
Cancer Lett
|
1995
|
1.48
|
|
2
|
A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.
|
Int J Cancer
|
1989
|
1.46
|
|
3
|
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
|
Cancer Res
|
2000
|
1.25
|
|
4
|
A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoral genetic heterogeneity and new genetic changes on recurrence.
|
J Pathol
|
2008
|
1.15
|
|
5
|
A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.
|
Oncogene
|
2006
|
1.01
|
|
6
|
The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.
|
Clin Exp Allergy
|
2010
|
0.96
|
|
7
|
mRNA expression profiling of phyllodes tumours of the breast: identification of genes important in the development of borderline and malignant phyllodes tumours.
|
J Pathol
|
2008
|
0.92
|
|
8
|
Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells.
|
Br J Cancer
|
1993
|
0.91
|
|
9
|
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts.
|
Int J Cancer
|
1999
|
0.89
|
|
10
|
Prognosis of synchronous bilateral breast cancer.
|
Br J Surg
|
2009
|
0.86
|
|
11
|
Clinical goals and performance measures for cholesterol management in secondary prevention of coronary heart disease.
|
JAMA
|
2000
|
0.81
|
|
12
|
Patterns of metastasis in women with metachronous contralateral breast cancer.
|
Br J Cancer
|
2012
|
0.79
|
|
13
|
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
|
Breast Cancer Res Treat
|
2014
|
0.76
|
|
14
|
Tracking the take - Using patient flow data to improve AMU performance and safety.
|
Acute Med
|
2016
|
0.75
|
|
15
|
Replacing short-acting nifedipine with alternative medications at a large health maintenance organization.
|
Am J Hypertens
|
1998
|
0.75
|